Skip to main content
Clinical Trials/ISRCTN65853476
ISRCTN65853476
Completed
N/A

Randomised controlled trial assessing efficacy of a novel cognitive behavioural therapy app for smoking cessation for healthy adults

Digital Therapeutics Inc.0 sites531 target enrollmentDecember 18, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tobacco use
Sponsor
Digital Therapeutics Inc.
Enrollment
531
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33021488/ results (added 08/10/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35470860/ Secondary outcomes (added 18/01/2023)

Registry
who.int
Start Date
December 18, 2018
End Date
January 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Digital Therapeutics Inc.

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 or older
  • 2\. Has been smoking at least five cigarettes a day for at least one year
  • 3\. Desires to quit in the next 30 days
  • 4\. Can attend appointments at one of several locations around London
  • 5\. Using Apple iPhone (5th generation or higher) or Android phone (version 18 or higher)
  • 6\. Working proficiency in English language

Exclusion Criteria

  • 1\. Currently using any other form of support for smoking cessation (including Bupropion, Varenicline, behavioural support) or any other stop smoking applications
  • 2\. Has a serious health condition (as decided by the study team)
  • 3\. Currently pregnant
  • 4\. Has a diagnosed mental health condition for which medication is currently being prescribed

Outcomes

Primary Outcomes

Not specified

Similar Trials